Skip to main content
editorial
. 2016 Nov 16;7(49):80111–80112. doi: 10.18632/oncotarget.13418

Figure 1.

Figure 1

A. Schematic representation of PET antagonist (Antago) indiscriminately binding receptors in a G-coupled (functional) and uncoupled (non-functional) receptor state. B. The PET agonist (Ago) binds specifically to the G-coupled receptor state (functional receptors). Note that radiopharmaceuticals, at tracer dose, occupy only a fraction of the available receptors.